Summary of Clinical Dosing for Parkinson's Disease
Study Title Key Findings Form Dose Year
Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease Acute CBD administration at a dose of 300 mg decreased anxiety in patients with PD, and there was also decreased tremor amplitude in an anxiogenic situation. Not Available CBD (300 mg) 2020
Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial. Findings point to a possible effect of CBD in improving quality of life measures in PD patients with no psychiatric comorbidities; however, studies with larger samples and specific objectives are required before definitive conclusions can be drawn. Not Available Three study groups: CBD (75 mg/day), CBD (300 mg/day), or placebo 2014